The Ethical Challenges of Drug Company Entrepreneurism in Modern Health Care

Hazlet T.K. , Sullivan S.D. Professional organizations and healthcare industry support: ethical conflict? Cambridge quarterly of healthcare ethics spring 1994; 3(2): 236–44.

Associated Press. Physician of last resort on trial over cancer “cure.” Chicago Tribune Jan. 6,1997; Sec. 1: 11.

Hutchcraft C. Baxter blood substitute gets testing boost from FDA. Chicago Tribune Nov. 11,1996: Sec. 3: 1.

Associated Press. Plan to give patients more data on prescription drugs is approved. Chicago Tribune Jan. 15, 1997; Sec. 1: 6.

Schulman K.A. , Rubenstein L.E. , Abernethy D.R. , Seils D.M. , Sulmasy D.P. The impact of pharmaceutical benefit managers: is it being evaluated? Ann Intern Med 1996; 124: 906–13.

Engelhardt H.T. Jr. , Rie M. Morality for the medical-industrial complex: a code of ethics for the mass marketing of healthcare. N Engl J Med 1988; 319: 1086–9.

Rothman D.J. The rising cost of pharmaceuticals: an ethicist's perspective. Am J Hospital Pharmacy 1993; 50(suppl.): S10–12.

Lowenthal W. Ethical dilemmas in pharmacy. J Med Eth Mar 1988; 14(1): 31–34.

Muller-Oerlinghausen B. Ethical problems in clinical psychopharmacology. International Journal of Clinical Pharmacology & Biopharmacy 1978; 16(10): 443–50.

Cohen L.P. Stuck for money: To screen new drugs for safety, Lilly pays homeless alcoholics. The Wall Street Journal Nov. 14, 1996.

Butler J.K. Is it ethical to conduct volunteer studies within the pharmaceutical industry? Lancet Apr. 15, 1978; 1(8068): 816–18.

Micetich K. Reflections of an IRB chair. Cambridge Quarterly of Healthcare Ethics 1994; 3(4): 506–9.

Engstrom A. Drugs, science and people. Acta Pharmaceutica Suecica Nov. 1973; 10(5): 353–58.

Shamoo A. , Keay T. Ethical concerns about relapse studies. Cambridge Quarterly of Healthcare Ethics 1996; 5(3): 373–386.

Berger B.A. Building an effective therapeutic alliance: competence, trustworthiness, and caring. Am J Hospital Pharmacy 1993; 50(11): 2399–403.

Pellegrino E.D. , Thomasma D.C. For the Patient's Good: The Restoration of Beneficence in Health Care. New York: Oxford University Press, 1988.

One contemporary arena of concern to pharmacists is the patient's “drug misadventures” consequent upon the resultant instinctive uses of different drugs. See: Redman BK. Drug misadventuring as an issue in the ethics of leadership. American Journal of Health-System Pharmacy Feb 15, 1995; 52(4): 404–5.

Hauerwas S. Suffering Presence. Edinburgh: T & T Clark, 1986: 6.

Glaser J.W. Three Realms of Ethics. Kansas City, MO: Sheed & Ward, 1994: 26–27.

Pellegrino Thomasma . For the Patient's Good, op. cit.

Campbell A.V. Dependency: the foundational value in medical ethics. In Fulford K.W.M. , Gillett G. , and Soskice J.M. , eds. Medicine and moral reasoning. Cambridge: Cambridge University Press, 1994: 184–192.

Pellegrino E.D. , Thomasma D.C. The Virtues in Medical Practice. New York: Oxford University Press, 1993.

Parsons C. Lawmakers renewing debate over hospital stays. Chicago Tribune Jan. 6, 1997; Sec 1: 1, 12.

Thomasma D. Promisekeeping: an institutional ethos for healthcare today. Frontiers of Health Services Management 1996; 13(2): 5–34.